GB201814764D0 - Pharmaceutical compositions for the treatment of proteinopathies - Google Patents
Pharmaceutical compositions for the treatment of proteinopathiesInfo
- Publication number
- GB201814764D0 GB201814764D0 GBGB1814764.5A GB201814764A GB201814764D0 GB 201814764 D0 GB201814764 D0 GB 201814764D0 GB 201814764 A GB201814764 A GB 201814764A GB 201814764 D0 GB201814764 D0 GB 201814764D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- proteinopathies
- treatment
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1814764.5A GB201814764D0 (en) | 2018-09-11 | 2018-09-11 | Pharmaceutical compositions for the treatment of proteinopathies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1814764.5A GB201814764D0 (en) | 2018-09-11 | 2018-09-11 | Pharmaceutical compositions for the treatment of proteinopathies |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201814764D0 true GB201814764D0 (en) | 2018-10-24 |
Family
ID=63921064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1814764.5A Ceased GB201814764D0 (en) | 2018-09-11 | 2018-09-11 | Pharmaceutical compositions for the treatment of proteinopathies |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201814764D0 (en) |
-
2018
- 2018-09-11 GB GBGB1814764.5A patent/GB201814764D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202004025B (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
EP3448874A4 (en) | Compositions for the treatment of disease | |
PL3785733T3 (en) | Pharmaceutical composition for the treatment of autism | |
IL271807A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis | |
IL261444A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis | |
ZA202007055B (en) | Compositions for the treatment of skin conditions | |
ZA202006610B (en) | Compositions for the treatment of skin conditions | |
IL272601A (en) | Pharmaceutical compositions for the treatment of ophthalmic conditions | |
IL279397A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
ZA202002166B (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
IL261278A (en) | Pharmaceutical compositions for the treatment of cancer | |
IL275525A (en) | Pharmaceutical composition for the treatment of cancer | |
PT3823655T (en) | Compositions for the treatment of vulvodynia | |
RS61747B1 (en) | Pharmaceutical composition for the treatment of constipation | |
GB201814764D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
SG11202112590WA (en) | Pharmaceutical compositions for the treatment of hbv | |
GB201719584D0 (en) | Pharmaceutical compositions for the treatment of cancer | |
GB201901130D0 (en) | Formulation for the treatment of tendinopathies | |
GB201720101D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
IL263336A (en) | Compositions for treatment of symphysiolysis | |
PT3785733T (en) | Pharmaceutical composition for the treatment of autism | |
GB201817343D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
GB201817344D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
GB201809836D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |